You seem to have invested in RSH for a long time when the company and product was under a different name, why wasn't this done then or even mentioned as a high priority when your much vaunted CEO took over?? I recall RSH wanted to enter the COPD market when MM joined and there was a study which was going to happen but haven't heard much about it since then.......
RSH Price at posting:
5.2¢ Sentiment: Hold Disclosure: Not Held
